Novo Nordisk Foundation
The Senior Scientific Manager - Innovation leads scientific initiatives within the Innovation department, driving research and development of new technologies. The role involves overseeing projects, collaborating across teams, and managing resources to deliver innovative solutions.
Headquarters
Hellerup, Hovedstaden, Denmark
Company Size
51-200 employees
Founded
1924
Novo Nordisk Fonden is a Danish philanthropic foundation that funds high-impact health and life sciences research and related initiatives. It supports basic, clinical, and translational biomedical research, as well as education, talent development, and strategic programs to strengthen Denmark’s life-sciences ecosystem. The foundation collaborates with universities, hospitals, and industry partners to accelerate scientific breakthroughs with potential to improve global health. Through long-term funding and strategic investments, Novo Nordisk Fonden strives to ensure societal benefit from science and research excellence.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk Foundation.
Novo Nordisk Foundation didn’t post a salary, so this is our estimate from similar listings.
38% below the average for this role
UPDATE: Novo Foundation Completes Board Takeover After Shareholder Pushback
Nov 14, 2025
Chief Scientific Officer
Legend Biotech
Senior Scientific Director for Mini Protein Discovery
State of Indiana
Innovation Lead
ATC Data Center Services
Bachelorarbeit - Datengesteuerte Inline-Messsysteme in der intelligenten Produktion
Fraunhofer-Gesellschaft
Bachelor-/ Masterarbeit: »Quantencomputer-gestützte Fertigungssimulation in der Zerspanung«
Fraunhofer-Gesellschaft
Masterarbeit: »Isolierung und Kultivierung von primären Hautzellen«
Fraunhofer-Gesellschaft